HC Wainwright & Co. Reiterates Neutral on Summit Therapeuticsto Neutral

ساميت ثيرابيوتكس

Summit Therapeutics Inc

SMMT

0.00

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Summit Therapeutics (NASDAQ: SMMT) from Neutral to Neutral.